
Based on the image provided, here is the technical breakdown and marketing copy for AMLOCOT-AT, featuring the combination of Amlodipine Besylate and Atenolol.
AMLOCOT-AT is a dual-action cardiovascular formulation designed to manage hypertension (high blood pressure) and improve heart efficiency. By combining a Calcium Channel Blocker (Amlodipine) with a Beta-blocker (Atenolol), it provides synergistic control for patients who require more than single-agent therapy.
Amlodipine Besylate: Relaxes and widens the blood vessels, improving blood flow and reducing the workload on the heart.
Atenolol: Slows down the heart rate and decreases the heart’s demand for oxygen, helping it pump more steadily.
Synergistic BP Control: Targets blood pressure through two distinct mechanisms for superior efficacy.
24-Hour Coverage: Designed for consistent blood pressure management throughout the day.
Cardio-Protective: Reduces the long-term risk of stroke, myocardial infarction, and other hypertensive complications.
Patient Compliance: Combines two essential medications into one tablet, reducing “pill burden.”
“Take control of your heart health with AMLOCOT-AT. By combining the vessel-relaxing power of Amlodipine with the steadying rhythm of Atenolol, AMLOCOT-AT ensures your heart works smarter, not harder. Precision care for a balanced life.”
Available in: $10 \times 10$ Tablets Blister Pack.
Theme: Use a palette of calm blues and clinical whites (matching the packaging).
Iconography: Use icons representing a steady heartbeat (ECG line) and relaxed blood vessels.
Call to Action (CTA): “Trust Accott Healthcare for your Cardiovascular Wellness. Visit www.accotthealthcare.com for more details.”
There are no reviews yet.